US Patent Issued to Xencor on Feb. 24 for "Compositions and methods for treating IgE-mediated disorders" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,572, issued on Feb. 24, was assigned to Xencor Inc. (Monrovia, Calif.).

"Compositions and methods for treating IgE-mediated disorders" was invented by John R Desjarlais (Pasadena, Calif.), Seung Y. Chu (Cypress, Calif.), Holly M. Horton (Boston) and Matthew J. Bernett (Monrovia, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to immunoglobulins that bind IgE and FcGammaRIIb with high affinity, said compositions being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma."

The patent was filed on Dec. 22, 202...